Amanote Research
Register
Sign In
Trastuzumab Biosimilar on Track for Approval
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-nb2017-115
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
August 16, 2017
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
An Overview of Current Regulatory Requirements for Approval of Biosimilar Insulins
Diabetes Technology and Therapeutics
Medicine
Endocrinology
Medical Laboratory Technology
Metabolism
Diabetes
Comparative Nonclinical Assessments of the Proposed Biosimilar PF-05280014 and Trastuzumab (Herceptin®)
BioDrugs
Medicine
Biotechnology
Pharmacology
A Rapid Method for Relative Quantification of N-Glycans From a Therapeutic Monoclonal Antibody During Trastuzumab Biosimilar Development
mAbs
Allergy
Immunology
A Phase I Dose-Escalation Study of a Biosimilar Trastuzumab in Chinese Metastasis Breast Cancer Patients
SpringerPlus
Multidisciplinary
Pcn103 - Predicted Treatment Costs and Savings Per Patient of Kanjinti® (Trastuzumab Biosimilar) vs. Subcutaneous (Sc) and Intravenous (Iv) Herceptin® and Other Trastuzumab Biosimilars in Italy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Case of Metastatic Extramammary Paget's Disease Treated With Trastuzumab‐biosimilar Monotherapy After S‐1 and Docetaxel Combination Chemotherapy
Journal of Dermatology
Dermatology
Medicine
A Convenor on Approval
Bulletin of the Royal College of Psychiatrists
Pcn69 - Budget Impact of Substituting Biosimilar Trastuzumab (Ct-P6) in Treating Gastric Cancer and Breast Cancer in 28 European Countries
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Experimental Study on Track-Bridge Interactions for Direct Fixation Track on Long-Span Railway Bridge
Shock and Vibration
Mechanics of Materials
Geotechnical Engineering
Condensed Matter Physics
Mechanical Engineering
Civil
Engineering Geology
Structural Engineering
